NCT00338442View on ClinicalTrials.gov

Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

APPROVED_FOR_MARKETINGEXPANDED_ACCESS
Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Varicella
Interventions
DRUG

VariZIG™

Biological / Vaccine

Sponsors
All Listed Sponsors
lead

Cangene Corporation

INDUSTRY